These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18211828)
1. GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis. Toyoda K; Okitsu T; Yamane S; Uonaga T; Liu X; Harada N; Uemoto S; Seino Y; Inagaki N Biochem Biophys Res Commun; 2008 Mar; 367(4):793-8. PubMed ID: 18211828 [TBL] [Abstract][Full Text] [Related]
2. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model. Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295 [TBL] [Abstract][Full Text] [Related]
3. Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts. Tian L; Gao J; Weng G; Yi H; Tian B; O'Brien TD; Guo Z Transpl Int; 2011 Aug; 24(8):856-64. PubMed ID: 21627696 [TBL] [Abstract][Full Text] [Related]
4. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome. Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218 [TBL] [Abstract][Full Text] [Related]
5. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats. Park S; Hong SM; Sung SR Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751 [TBL] [Abstract][Full Text] [Related]
6. Improved outcome of islet transplantation in insulin-treated diabetic mice: effects on beta-cell mass and function. Merino JF; Nacher V; Raurell M; Aranda O; Soler J; Montanya E Diabetologia; 1997 Sep; 40(9):1004-10. PubMed ID: 9300236 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Miao G; Mace J; Kirby M; Hopper A; Peverini R; Chinnock R; Shapiro J; Hathout E Transplantation; 2006 Feb; 81(4):519-24. PubMed ID: 16495797 [TBL] [Abstract][Full Text] [Related]
8. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal. Jalili RB; Moeen Rezakhanlou A; Hosseini-Tabatabaei A; Ao Z; Warnock GL; Ghahary A J Cell Physiol; 2011 Jul; 226(7):1813-9. PubMed ID: 21506112 [TBL] [Abstract][Full Text] [Related]
10. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model. Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB Islets; 2010; 2(1):18-23. PubMed ID: 21099289 [TBL] [Abstract][Full Text] [Related]
11. Exendin-4 increases the expression of hypoxia-inducible factor-1α in rat islets and preserves the endocrine cell volume of both free and macroencapsulated islet grafts. Jia X; Sharma A; Kumagai-Braesch M; Wernerson AM; Sörenby AK; Yamamoto S; Wang F; Tibell AB Cell Transplant; 2012; 21(6):1269-83. PubMed ID: 22405036 [TBL] [Abstract][Full Text] [Related]
12. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Merani S; Truong W; Emamaullee JA; Toso C; Knudsen LB; Shapiro AM Endocrinology; 2008 Sep; 149(9):4322-8. PubMed ID: 18511515 [TBL] [Abstract][Full Text] [Related]
13. Improved outcome of islet transplantation in partially pancreatectomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin. Kim YS; Oh SH; Park KS; No H; Oh BJ; Kim SK; Jung HS; Kim JH; Lee MS; Lee MK; Kim KW Pancreas; 2011 Aug; 40(6):855-60. PubMed ID: 21747318 [TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor. Wu Z; Todorov I; Li L; Bading JR; Li Z; Nair I; Ishiyama K; Colcher D; Conti PE; Fraser SE; Shively JE; Kandeel F Bioconjug Chem; 2011 Aug; 22(8):1587-94. PubMed ID: 21692471 [TBL] [Abstract][Full Text] [Related]
15. Generation of functional islet-like clusters after monolayer culture and intracapsular aggregation of adult human pancreatic islet tissue. Tsang WG; Zheng T; Wang Y; Tang J; Rind HB; Francki A; Bufius N Transplantation; 2007 Mar; 83(6):685-93. PubMed ID: 17414699 [TBL] [Abstract][Full Text] [Related]
16. Effect of glucagon-like peptide-1 gene expression on graft function in mouse islet transplantation. Chae HY; Kang JG; Kim CS; Lee SJ; Lee M; Kang D; Jun HS; Ihm SH Transpl Int; 2012 Feb; 25(2):242-9. PubMed ID: 22171669 [TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. Wu Z; Liu S; Hassink M; Nair I; Park R; Li L; Todorov I; Fox JM; Li Z; Shively JE; Conti PS; Kandeel F J Nucl Med; 2013 Feb; 54(2):244-51. PubMed ID: 23297075 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Kim SJ; Nian C; Doudet DJ; McIntosh CH Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314 [TBL] [Abstract][Full Text] [Related]
19. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist. Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761 [TBL] [Abstract][Full Text] [Related]
20. Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets. Cheng G; Zhu L; Mahato RI Mol Pharm; 2008; 5(6):1093-102. PubMed ID: 18828606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]